Spinal cord stimulation is a $2-3billion market, despite limited efficacy. A placebo controlled trial of spinal cord bur
Tweet Content
Spinal cord stimulation is a $2-3billion market, despite limited efficacy. A placebo controlled trial of spinal cord burst stimulation, in 50 pts w/ chr radicular pain after lumbar surgery, showed no significant benefit in back pain–related disability. https://t.co/aRN5sRbqFx https://t.co/A37LWaYEGw
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off